Psykey, Inc. (OTCMKTS:CEOS) Short Interest Update

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large drop in short interest in December. As of December 15th, there was short interest totaling 2,400 shares, a drop of 60.1% from the November 30th total of 6,013 shares. Based on an average daily volume of 147,973 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 147,973 shares, the days-to-cover ratio is currently 0.0 days.

Psykey Price Performance

Shares of CEOS stock opened at $0.00 on Friday. Psykey has a 12 month low of $0.00 and a 12 month high of $0.04.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.